Connect with us

Hi, what are you looking for?

Jewish Business News

Business

Chinese Bright Food to compensate Apax over delay in deal Of Israel’s Largest Food Wholesaler

The Chinese company will pay Tnuva’s controlling shareholders $29.4 million.

 

Photo Tamar Mazafi- Tnuva 575.20121107T110746

 

Apax Partners, managed in Israel by Zehavit Cohen, and Chinese food giant Bright Food has signed an agreement for another three-month extension of the Tnuva Food Industries Ltd. deal until April 2, 2015 at the latest, as of now. In return for the extension, it was agreed that Tnuva’s value for the deal would be $2.20 billion (the original value for the deal), and that the Chinese company would pay Apax Partners and Mivtach Shamir Holdings Ltd. (TASE:MISH) an additional $29.4 million, to be divided according to their relative stakes in Tnuva) in compensation for the extension.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.

Mivtach Shamir today announced that the company’s pre-tax profit on the deal, if and when it goes through, is expected to reach $179.4 million.

Bright Food had to postpone the deal, not for the first time, after having trouble paying $461 million for the purchase of Mivtach Shamir’s 21% stake in Tnuva. Incidentally, the current extension is divided into two: until March 24, with an option for Bright Food for an extension until April 2. Several restrictions, including the distribution of dividends, will apply to Tnuva until that date.

The current extension of the deadline for completing the huge deal was apparently given because Mivtach Shamir, controlled by Meir Shamir, decided to exercise its option to join the sale of shares by Apax Partners, Tnuva’s controlling shareholder.

Sources with knowledge about the negotiations for completing the deal believe that the reason for the additional extension of the deal signed in May 2014 is that the Chinese company has not yet found an approved solution for acquiring Mivtach Shamir’s share. The additional time is therefore designed to enable Bright Food to bring a buyer for Mivtach Shamir’s share of Tnuva, or to obtain approval and financing for buying Mivtach Shamir’s holdings itself.

Bright Food has been negotiating in recent weeks to retain Meir Shamir as part of the controlling interest. Shamir demanded in return an option to sell his Tnuva holdings to Bright Food at the same company value granted to Apax, plus a guarantee to safeguard the exercise of the option.

The Chinese company refused to provide Shamir with a guarantee, however, and Shamir therefore announced that he would exercise his option now to join the Apax-Bright Food deal at the same company value for Tnuva given to Apax. Mivtach Shamir has announced that the negotiations were unsuccessful, and it would sell its stake together with Apax when the deal is completed. At the same time, it cannot be totally ruled out that Bright Food will decide later, given its current difficulties, to give Mivtach Shamir the guarantee it is demanding.

In any case, Bright Food has given the impression up until now that if Shamir decides to exit Tnuva, it would bring in a partner to buy his shares. It now emerges that the subject of buying Shamir’s stake is far from settled, with Bright Food being stymied at the moment. As far as is known, Bright Food will either have to find a partner to acquire Mivtach Shamir’s share, or solve the problem of financing the acquisition and obtaining regulatory approval in China for this additional acquisition (beyond the 56% Tnuva stake being acquired from Apax).

Published by Globes [online], Israel business news – www.globes-online.com

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Life-Style Health

Medint’s medical researchers provide data-driven insights to help patients make decisions; It is affordable- hundreds rather than thousands of dollars

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...